Literature DB >> 19129258

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.

Pengcheng Luo1, Yiqiang Zhou, Hsin-Hsin Chang, Jie Zhang, Tsugio Seki, Cong-Yi Wang, Edward W Inscho, Mong-Heng Wang.   

Abstract

The early stage of diabetic nephropathy (DN) is linked to proteinuria. Transforming growth factor (TGF)-beta1 increases glomerular permeability to albumin (P(alb)), whereas 20-HETE and EETs reduce P(alb). To investigate the impact of hyperglycemia and hyperlipidemia on 20-HETE, EETs, and TGF-beta1 in the glomeruli, rats were divided into four groups: ND rats were fed a normal diet, HF rats were fed a high-fat diet, STZ rats were treated with 35 mg/kg of streptozotocin, and HF/STZ rats were fed a HF diet and treated with STZ. After 10 wk on these regimens, blood glucose, urinary albumin, serum cholesterol, serum triglyceride levels, and the kidney-to-body weight ratio were significantly elevated in STZ and HF/STZ rats compared with HF and ND rats. STZ and HF/STZ rats had histopathologic changes and abnormal renal hemodynamics. Expression of glomerular CYP4A, enzymes for 20-HETE production, was significantly decreased in STZ rats, whereas expression of glomerular CYP2C and CYP2J, enzymes for EETs production, was significantly decreased in both STZ and HF/STZ rats. Moreover, glomerular TGF-beta1 levels were significantly greater in STZ and HF/STZ rats than in HF and ND rats. Five-week treatment of STZ rats with clofibrate induced glomerular CYP4A expression and 20-HETE production, but reduced glomerular TGF-beta1 and urinary protein excretion. These results demonstrate that hyperglycemia increases TGF-beta1 but decreases 20-HETE and EETs production in the glomeruli, changes that may be important in causing glomerular damage in the early stage of DN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19129258      PMCID: PMC2660192          DOI: 10.1152/ajprenal.90613.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  42 in total

1.  Renoprotective effects of fenofibrate in diabetic rats are achieved by suppressing kidney plasminogen activator inhibitor-1.

Authors:  Lu-Lu Chen; Jiao-Yue Zhang; Bao-Ping Wang
Journal:  Vascul Pharmacol       Date:  2006-04-19       Impact factor: 5.773

2.  Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.

Authors:  Annette J Dahly-Vernon; Mukut Sharma; Ellen T McCarthy; Virginia J Savin; Steven R Ledbetter; Richard J Roman
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

Review 3.  Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.

Authors:  John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2005-09

4.  Gender differences of renal CYP-derived eicosanoid synthesis in rats fed a high-fat diet.

Authors:  Yiqiang Zhou; Songbai Lin; Hsin-Hsin Chang; Juan Du; Zheng Dong; Anne M Dorrance; Michael W Brands; Mong-Heng Wang
Journal:  Am J Hypertens       Date:  2005-04       Impact factor: 2.689

5.  Regulation of P-450 4A activity in the glomerulus of the rat.

Authors:  O Ito; R J Roman
Journal:  Am J Physiol       Date:  1999-06

6.  Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.

Authors:  Yiqiang Zhou; Hui Huang; Hsin-Hsin Chang; Juan Du; Jing Feng Wu; Cong-Yi Wang; Mong-Heng Wang
Journal:  J Pharmacol Exp Ther       Date:  2005-12-08       Impact factor: 4.030

7.  PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.

Authors:  C W Park; Y Zhang; X Zhang; J Wu; L Chen; D R Cha; D Su; M-T Hwang; X Fan; L Davis; G Striker; F Zheng; M Breyer; Y Guan
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

8.  Kidney involvement in a nongenetic rat model of type 2 diabetes.

Authors:  Ratna S Danda; Nusrath M Habiba; Hernan Rincon-Choles; Basant K Bhandari; Jeffrey L Barnes; Hanna E Abboud; Pablo E Pergola
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

9.  The CYP4A isoforms hydroxylate epoxyeicosatrienoic acids to form high affinity peroxisome proliferator-activated receptor ligands.

Authors:  L Ashley Cowart; Shouzuo Wei; Mei-Hui Hsu; Eric F Johnson; Murali U Krishna; John R Falck; Jorge H Capdevila
Journal:  J Biol Chem       Date:  2002-07-17       Impact factor: 5.157

10.  Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction.

Authors:  Hongmei Chen; Sachin Brahmbhatt; Akanksha Gupta; Avadhesh C Sharma
Journal:  Cardiovasc Diabetol       Date:  2005-03-05       Impact factor: 9.951

View more
  21 in total

1.  Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

Authors:  Ahmed A Elmarakby; Jessica Faulkner; Mohammed Al-Shabrawey; Mong-Heng Wang; Krishna Rao Maddipati; John D Imig
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-10       Impact factor: 3.619

Review 2.  The Role of Cytochrome P450 Epoxygenases, Soluble Epoxide Hydrolase, and Epoxyeicosatrienoic Acids in Metabolic Diseases.

Authors:  Xizhen Xu; Rui Li; Guangzhi Chen; Samantha L Hoopes; Darryl C Zeldin; Dao Wen Wang
Journal:  Adv Nutr       Date:  2016-11-15       Impact factor: 8.701

Review 3.  Eicosanoids, β-cell function, and diabetes.

Authors:  Pengcheng Luo; Mong-Heng Wang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-07-03       Impact factor: 3.072

Review 4.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

Review 5.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

6.  CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.

Authors:  Rui Li; Xizhen Xu; Chen Chen; Yan Wang; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-11-11       Impact factor: 4.310

Review 7.  The transcriptional regulation of the human CYP2C genes.

Authors:  Yuping Chen; Joyce A Goldstein
Journal:  Curr Drug Metab       Date:  2009-07-15       Impact factor: 3.731

8.  20-HETE induces hyperglycemia through the cAMP/PKA-PhK-GP pathway.

Authors:  Guangrui Lai; Jingjing Wu; Xiaoliang Liu; Yanyan Zhao
Journal:  Mol Endocrinol       Date:  2012-08-23

9.  Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats.

Authors:  Yoshikazu Muroya; Osamu Ito
Journal:  Clin Exp Nephrol       Date:  2016-03-07       Impact factor: 2.801

10.  Role of soluble epoxide hydrolase in exacerbation of stroke by streptozotocin-induced type 1 diabetes mellitus.

Authors:  Sari A Jouihan; Kristen L Zuloaga; Wenri Zhang; Robert E Shangraw; Stephanie M Krasnow; Daniel L Marks; Nabil J Alkayed
Journal:  J Cereb Blood Flow Metab       Date:  2013-07-31       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.